NeoGenomics Launches $275M Private Offering of Convertible Notes
NeoGenomics announced that it has commenced a private offering of $275M aggregate principal amount of convertible senior notes due 2032 to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.
